We initially examined the intra-tumoral cytolytic activity (CYT) score of each tumor, a quantitative measure of immune cytolytic activity based on transcript levels of two cytolytic effectors, granzyme A (GZMA) and perforin (PRF1)24. This evidence concerns the gene GZMA and neoplasm.